Board of Directors

Mr. Evans was named Chairman of the Board of Directors in June 2018, and has over 40 years of experience in the healthcare industry. He is currently President of the International Health Services Group, an organization he founded to support health services development in underserved areas of the world. He also currently is a senior advisor with Jackson Healthcare, a consortium of companies that provide physician and clinical staffing, anesthesia management and information technology solutions for hospitals, health systems and physician groups. In addition, Mr. Evans is a Fellow in the American College of Healthcare Executives having previously served as Governor of the College from 2004 to 2007 and as Chairman Officer from 2008 to 2011. In 2012, he attained the Board Leadership Fellow credential of the National Association of Corporate Directors. Previously, Mr. Evans was a senior officer with Hospital Corporation of America (HCA), having managed various HCA divisions and completing his service with the responsibility for operations in the Eastern half of the country. Mr. Evans currently serves on the Board of Directors of Jackson Healthcare. Additionally, Mr. Evans serves on the boards of non-profit organizations including MedShare International and the Hospital Charitable Service Awards.

Luis A. Aguilar served as a Commissioner at the U.S. Securities and Exchange Commission from July 31, 2008 to December 31, 2015, and was the eighth longest-serving Commissioner in SEC history. Currently he serves on the Boards of Directors of Envestnet, Inc. (NYSE: ENV) and Donnelley Financial Solutions, Inc. (NYSE: DFIN). Commissioner Aguilar is also a partner in Falcon Cyber Investments, a multistage equity investment vehicle exclusively focused on Cybersecurity Investments.

Commissioner Aguilar’s previous experience includes serving as the general counsel, head of compliance, executive vice president, and corporate secretary of Invesco. His career includes tenure as a partner at the following prominent national law firms: McKenna Long & Aldridge, LLP (subsequently merged with Dentons US LLP); Alston & Bird LLP; Kilpatrick Townsend & Stockton LLP; and Powell Goldstein Frazer & Murphy LLP (subsequently merged with Bryan Cave LLP). He began his legal career as an attorney at the U.S. Securities and Exchange Commission.

He has been active in numerous civic and business associations including the Latin American Association. He has served on various Boards, including the Girl Scouts Council of Northwest Georgia, Inc., Georgia Hispanic Bar Association, United States Fund for UNICEF Southeast Regional Chapter, the Mexican American Legal Defense and Education Fund (MALDEF), Leadership Atlanta, and CIFAL Atlanta, Inc. He has been very active with national organizations such as the Hispanic National Bar Association. In addition, he served as the President of the Hispanic National Bar Foundation from September 2006 to July 2008.

He is a graduate of the University of Georgia School of Law, and also received a master of laws degree in taxation from Emory University. He has successfully completed Series 7, 24, 63, and 65 examinations in connection with serving as president and a director of a registered broker-dealer.

Mr. Bleser became a financial consultant serving public and private companies in the healthcare and technology industries in 1998 after serving for over 20 years as Chief Financial Officer for several public companies in the healthcare and technology industries, including HBO & Company, Allegiant Physician Services, and Transcend Services, and Healthcare.com, a Matria Healthcare public subsidiary. Mr. Bleser is a member of the Board of Directors, the Audit Committee and the Corporate Governance Committee of Transcend Services [NASDAQ: TRCR]. In addition, Mr. Bleser serves on the Board of Directors of a privately held information technology solutions company. Mr. Bleser is a licensed Certified Public Accountant with ten prior years of public accounting experience in an international public accounting firm.

Mr. J. Terry Dewberry, is a private investor with extensive experience at both the management and board levels in the healthcare industry. He most recently served as a Director with Respironics, Inc. and Matria Healthcare, Inc. where he served as a member of various committees including the Audit and Compensation committees. In 2008 both Respironics and Matria Healthcare were sold to larger companies. He currently serves on the board of DrTango, Inc., a private company in the multicultural communications and health management industry. He served as a Director, Vice Chairman, President and Chief Operating Officer, Executive Vice President and Chief Financial Officer of Healthdyne, Inc from 1981 to 1996. He has extensive experience in corporate mergers and takeovers on both the buy and sell sides at sizes up to $5 billion.

Bruce Hack is founder and CEO of BLH Venture, LLC, a provider of strategy and operating advice to media and entertainment companies. He is a Director on public and private boards including Technicolor (TCH), MiMedx Group (MDXG) and numerous early/mid stage online and mobile firms. Mr. Hack was a principal in the creation of Activision Blizzard, the largest video game company in the world, and served as its Vice Chairman in 2009. From 2004-2008, he was CEO of Vivendi Games, the developer and operator of numerous franchises including Blizzard’s World of Warcraft, the world’s largest subscription-based online game. Previously, Mr. Hack was Vice Chairman of the Board, Universal Music Group, the world’s largest music company, from 1998 to 2001, and CFO, Universal Studios, from 1995 to 1998. He joined the Seagram Company Ltd. in 1982 after serving as an international trade negotiator at the U.S. Treasury in Washington, D.C. Amongst his roles at Seagram were CFO of Tropicana Products, Inc. and Director, Strategic Planning, at The Seagram Company Ltd. Mr. Hack guest lectures on leadership and entrepreneurship at Stanford, Princeton, Yale and Cornell Universities. He earned a B.A. from Cornell and an M.B.A from the University of Chicago.

Mr. Koob joined the law firm of Simpson Thacher & Bartlett, LLP in 1970 and became a partner in 1977. He retired from that firm on January 1, 2007 but remains of counsel. While at that firm, Mr. Koob was the co-head of the Litigation Department and served on the Firm's Executive Committee. Mr. Koob specializes in competition, trade regulation and antitrust issues. Throughout his 37-year tenure, he has represented clients before the Federal Trade Commission, the Antitrust Division of the Department of Justice, and numerous state and foreign competition authorities. His resume includes the representation of Virgin Atlantic Airways, Archer Daniels Midland, and Kohlberg Kravis Roberts and Co. He received his B.A. from Rockhurst College in 1966 and his J.D. from Stanford Law School in 1969. In addition to his practice, Mr. Koob is trustee of the Natural Resources Defense Council, is President of the Yellowstone Park Foundation and is the co-chair of the Steering Committee for the current campaign for Stanford Law School. Mr. Koob is the brother of Dr. Thomas J. Koob, Chief Scientific Officer of MiMedx Group.

From July 1991 until his retirement in May 2002, Mr. Papasan served as President of Smith & Nephew Orthopaedics. He has been a Director and Chairman of the Board of Directors of BioMimetic Therapeutics [NasdaqGM:BMTI] since August 2005. BioMimetic Therapeutics, Inc. is developing and commercializing bio-active recombinant protein-device combination products for the healing of musculoskeletal injuries and disease, including orthopedic, periodontal, spine and sports injury applications. Mr. Papasan has also served as a member of the Board of Directors of Reaves Utility Income Fund [NasdaqCM:UTG], a closed-end management investment company, since February 2003 and of Triumph Bankshares, Inc. (a bank holding company) since April 2005. Mr. Papasan also serves as a Director of SSR Engineering, Inc. and AxioMed Spine Corporation.

Neil S. Yeston, M.D. serves on our Board of Directors. Dr. Yeston became a director of the Company in September 2012. Dr. Yeston currently serves as Active Senior Staff, Department of Surgery at Hartford Hospital. During his association with Hartford Hospital, Dr. Yeston previously served in various roles including Vice President of Academic Affairs, Director of Corporate Compliance, Vice President of Quality Management and Director of the Section on Critical Care Medicine, Department of Surgery. Dr. Yeston has formerly served as Professor of Surgery at the University of Connecticut and the Assistant Dean, Medical Education at the University of Connecticut School of Medicine. Prior to his associations with Hartford Hospital and the University of Connecticut, Dr. Yeston served with Boston University Medical Center in various positions including the Vice Chairman, Department of Surgery; Associate Professor of Anesthesiology; Director Progressive Care Unit; and Associate Professors of Surgery.